Stay up to date with the latest news and events. Keep checking back here for regular updates on what is happening at Sri Krishna Pharmaceuticals.
15th August 2025
We are proud to announce that Sri Krishna Pharma has now received the EIR from the USFDA for the successful audit of two of its manufacturing facilities (Bollaram & Uppal).
This achievement reflects our unwavering commitment to the highest standards of quality, safety and compliance. Passing these rigorous inspections reinforces our readiness to serve regulated markets, strengthens our position as a trusted global pharmaceutical partner and underscores our dedication to delivering products that meet and exceed international benchmarks.
Inspection Dates:
Unit 1 (Uppal): April 14th to 18th 2025
Unit 4 (Bollaram): April 7th to 11th 2025
21st March 2025
It was a pleasure attending DCAT Week 2025, especially as we celebrate our 50th anniversary this year. For SKPL, DCAT Week is an invaluable opportunity to connect, share insights, and strengthen relationships with both long-standing clients and new partners.
Building these strong connections is at the heart of what we do, and we truly appreciate the time spent in these meaningful discussions. We look forward to continuing to grow together and hope to see you again soon.
